Effects of Sulforaphane (SFN)on Innate Immune Responses to Live Attenuated Influenza Virus in Smokers and Nonsmokers.

Trial Profile

Effects of Sulforaphane (SFN)on Innate Immune Responses to Live Attenuated Influenza Virus in Smokers and Nonsmokers.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jan 2014

At a glance

  • Drugs Influenza virus vaccine live (Primary) ; Sulforafan
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top